UPL (UPLL IN): Buy: 1QFY27 in-line; a resilient performance

Research evidence excerpt

UPL (UPLL IN): Buy: 1QFY27 in-line; a resilient performance

Securities Limited holds 1% or more of a class of common equity securities of this company.

HSBC and its affiliates will from time to time sell to and buy from customers the securities/instruments, both equity and debt

(including derivatives) of companies covered in HSBC Research on a principal or agency basis or act as a market maker or

liquidity provider in the securities/instruments mentioned in this report.

Analysts, economists, and strategists are paid in part by reference to the profitability of HSBC which includes investment banking,

sales & trading, and principal trading revenues.

Whether, or in what time frame, an update of this analysis will be published is not determined in advance.

Non-U.S. analysts may not be associated persons of HSBC Securities (USA) Inc, and therefore may not be subject to FINRA

Rule 2241 or FINRA Rule 2242 restrictions on communications with the subject company, public appearances and trading

securities held by the analysts.

Economic sanctions laws imposed by certain jurisdictions such as the US, the EU, the UK, and others, may prohibit persons

subject to those laws from making certain types of investments, including by transacting or dealing in securities of particular

issuers, sectors, or regions. This report does not constitute advice in relation to any such laws and should not be construed as an

inducement to transact in securities in breach of such laws.

For disclosures in respect of any company mentioned in this report, please see the most recently published report on that company

available at www.hsbcnet.com/research. HSBC Private Bank clients should contact their Relationship Manager for queries

regarding other research reports.